The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
Northern Clinics of Istanbul · 11.05.2026 · 13 (2) · 179-184
DOI: 10.14744/nci.2026.49035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Northern Clinics of Istanbul, online erschienen am 11.05.2026. Verfasst von Irem Bilgetekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Memorial Ankara Hospital, Ankara, Turkiye.
- Department of Urology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkiye.
- Department of Medical Oncology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkiye.
- Department of Medical Oncology, Losante Children's and Adult Hospital, Ankara, Turkiye.
- Department of Medical Oncology, Etlik City Hospital, Ankara, Turkiye.
Zitieren
APA
Bilgetekin, I., Ozturk, E., Karacin, C., Basal, F. B., Akdagcik, Z., & Oksuzoglu, B. (2026). The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. Northern Clinics of Istanbul, 13(2), 179-184. https://doi.org/10.14744/nci.2026.49035
Vancouver
Bilgetekin I, Ozturk E, Karacin C, Basal FB, Akdagcik Z, Oksuzoglu B. The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. Northern Clinics of Istanbul. 2026;13(2):179-184. doi:10.14744/nci.2026.49035
BibTeX
@article{Bilgetekin2026,
author = {Bilgetekin, Irem and Ozturk, Erdem and Karacin, Cengiz and Basal, Fatma Bugdayci and Akdagcik, Zeynep and Oksuzoglu, Berna},
title = {The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors},
journal = {Northern Clinics of Istanbul},
year = {2026},
volume = {13},
number = {2},
pages = {179--184},
doi = {10.14744/nci.2026.49035}
}
EUVIMED